Merit Medical Systems, Inc. (NASDAQ:MMSI – Get Free Report) has been assigned an average rating of “Moderate Buy” from the twelve analysts that are presently covering the company, MarketBeat Ratings reports. Two investment analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has assigned a strong buy rating to the company. The average 1-year price objective among brokers that have updated their coverage on the stock in the last year is $101.82.
MMSI has been the topic of a number of analyst reports. Robert W. Baird initiated coverage on Merit Medical Systems in a report on Friday, June 28th. They issued an “outperform” rating and a $96.00 price objective on the stock. Bank of America lifted their price target on shares of Merit Medical Systems from $92.00 to $103.00 and gave the company a “neutral” rating in a research report on Monday, September 16th. Needham & Company LLC reiterated a “buy” rating and set a $105.00 price target on shares of Merit Medical Systems in a research report on Monday, September 16th. Baird R W upgraded Merit Medical Systems to a “strong-buy” rating in a research report on Friday, June 28th. Finally, Barrington Research upped their target price on Merit Medical Systems from $100.00 to $114.00 and gave the company an “outperform” rating in a report on Friday, September 20th.
Get Our Latest Stock Report on Merit Medical Systems
Institutional Investors Weigh In On Merit Medical Systems
Merit Medical Systems Price Performance
Shares of MMSI opened at $95.63 on Wednesday. Merit Medical Systems has a twelve month low of $62.58 and a twelve month high of $101.60. The stock’s 50 day moving average is $94.08 and its two-hundred day moving average is $84.76. The firm has a market capitalization of $5.56 billion, a PE ratio of 54.96, a P/E/G ratio of 2.52 and a beta of 0.87. The company has a current ratio of 6.24, a quick ratio of 4.64 and a debt-to-equity ratio of 0.62.
Merit Medical Systems (NASDAQ:MMSI – Get Free Report) last announced its quarterly earnings data on Thursday, August 1st. The medical instruments supplier reported $0.92 earnings per share for the quarter, beating analysts’ consensus estimates of $0.88 by $0.04. Merit Medical Systems had a return on equity of 15.29% and a net margin of 9.02%. The company had revenue of $338.00 million for the quarter, compared to analyst estimates of $334.94 million. Research analysts anticipate that Merit Medical Systems will post 3.31 earnings per share for the current year.
Merit Medical Systems Company Profile
Merit Medical Systems, Inc designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions.
Recommended Stories
- Five stocks we like better than Merit Medical Systems
- Earnings Per Share Calculator: How to Calculate EPS
- The Outlook for Interest Rate Cuts Got Blown Out of the Water
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- 3 High-Risk, High-Reward Micro-Cap Stocks You Shouldn’t Ignore
- What is the Australian Securities Exchange (ASX)
- 3 Bargain Stocks Positioned for Gains After Missing 2024’s Rally
Receive News & Ratings for Merit Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merit Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.